290 related articles for article (PubMed ID: 29886828)
1. Development of MTL-CEBPA: Small Activating RNA Drug for Hepatocellular Carcinoma.
Setten RL; Lightfoot HL; Habib NA; Rossi JJ
Curr Pharm Biotechnol; 2018; 19(8):611-621. PubMed ID: 29886828
[TBL] [Abstract][Full Text] [Related]
2. Development and Mechanism of Small Activating RNA Targeting CEBPA, a Novel Therapeutic in Clinical Trials for Liver Cancer.
Voutila J; Reebye V; Roberts TC; Protopapa P; Andrikakou P; Blakey DC; Habib R; Huber H; Saetrom P; Rossi JJ; Habib NA
Mol Ther; 2017 Dec; 25(12):2705-2714. PubMed ID: 28882451
[TBL] [Abstract][Full Text] [Related]
3. Mechanisms involved in the activation of C/EBPα by small activating RNA in hepatocellular carcinoma.
Zhao X; Reebye V; Hitchen P; Fan J; Jiang H; Sætrom P; Rossi J; Habib NA; Huang KW
Oncogene; 2019 May; 38(18):3446-3457. PubMed ID: 30643190
[TBL] [Abstract][Full Text] [Related]
4. MTL-CEBPA, a Small Activating RNA Therapeutic Upregulating C/EBP-α, in Patients with Advanced Liver Cancer: A First-in-Human, Multicenter, Open-Label, Phase I Trial.
Sarker D; Plummer R; Meyer T; Sodergren MH; Basu B; Chee CE; Huang KW; Palmer DH; Ma YT; Evans TRJ; Spalding DRC; Pai M; Sharma R; Pinato DJ; Spicer J; Hunter S; Kwatra V; Nicholls JP; Collin D; Nutbrown R; Glenny H; Fairbairn S; Reebye V; Voutila J; Dorman S; Andrikakou P; Lloyd P; Felstead S; Vasara J; Habib R; Wood C; Saetrom P; Huber HE; Blakey DC; Rossi JJ; Habib N
Clin Cancer Res; 2020 Aug; 26(15):3936-3946. PubMed ID: 32357963
[TBL] [Abstract][Full Text] [Related]
5. Gene activation of CEBPA using saRNA: preclinical studies of the first in human saRNA drug candidate for liver cancer.
Reebye V; Huang KW; Lin V; Jarvis S; Cutilas P; Dorman S; Ciriello S; Andrikakou P; Voutila J; Saetrom P; Mintz PJ; Reccia I; Rossi JJ; Huber H; Habib R; Kostomitsopoulos N; Blakey DC; Habib NA
Oncogene; 2018 Jun; 37(24):3216-3228. PubMed ID: 29511346
[TBL] [Abstract][Full Text] [Related]
6. MTL-CEBPA Combined with Immunotherapy or RFA Enhances Immunological Anti-Tumor Response in Preclinical Models.
Huang KW; Tan CP; Reebye V; Chee CE; Zacharoulis D; Habib R; Blakey DC; Rossi JJ; Habib N; Sodergren MH
Int J Mol Sci; 2021 Aug; 22(17):. PubMed ID: 34502076
[TBL] [Abstract][Full Text] [Related]
7. Upregulation of C/EBPα Inhibits Suppressive Activity of Myeloid Cells and Potentiates Antitumor Response in Mice and Patients with Cancer.
Hashimoto A; Sarker D; Reebye V; Jarvis S; Sodergren MH; Kossenkov A; Sanseviero E; Raulf N; Vasara J; Andrikakou P; Meyer T; Huang KW; Plummer R; Chee CE; Spalding D; Pai M; Khan S; Pinato DJ; Sharma R; Basu B; Palmer D; Ma YT; Evans J; Habib R; Martirosyan A; Elasri N; Reynaud A; Rossi JJ; Cobbold M; Habib NA; Gabrilovich DI
Clin Cancer Res; 2021 Nov; 27(21):5961-5978. PubMed ID: 34407972
[TBL] [Abstract][Full Text] [Related]
8. Anti-inflammatory Activity of MTL-CEBPA, a Small Activating RNA Drug, in LPS-Stimulated Monocytes and Humanized Mice.
Zhou J; Li H; Xia X; Herrera A; Pollock N; Reebye V; Sodergren MH; Dorman S; Littman BH; Doogan D; Huang KW; Habib R; Blakey D; Habib NA; Rossi JJ
Mol Ther; 2019 May; 27(5):999-1016. PubMed ID: 30852139
[TBL] [Abstract][Full Text] [Related]
9. Treatment of Liver Cancer by C/EBPA saRNA.
Zhao X; Voutila J; Ghobrial S; Habib NA; Reebye V
Adv Exp Med Biol; 2017; 983():189-194. PubMed ID: 28639200
[TBL] [Abstract][Full Text] [Related]
10. RNA Activation-A Novel Approach to Therapeutically Upregulate Gene Transcription.
Tan CP; Sinigaglia L; Gomez V; Nicholls J; Habib NA
Molecules; 2021 Oct; 26(21):. PubMed ID: 34770939
[TBL] [Abstract][Full Text] [Related]
11. The Therapeutic Potential of Small Activating RNAs for Colorectal Carcinoma.
Zheng B; Mai Q; Jiang J; Zhou Q
Curr Gene Ther; 2019; 19(3):140-146. PubMed ID: 31284860
[TBL] [Abstract][Full Text] [Related]
12. Developing small activating RNA as a therapeutic: current challenges and promises.
Kwok A; Raulf N; Habib N
Ther Deliv; 2019 Mar; 10(3):151-164. PubMed ID: 30909853
[TBL] [Abstract][Full Text] [Related]
13. Small activating RNA binds to the genomic target site in a seed-region-dependent manner.
Meng X; Jiang Q; Chang N; Wang X; Liu C; Xiong J; Cao H; Liang Z
Nucleic Acids Res; 2016 Mar; 44(5):2274-82. PubMed ID: 26873922
[TBL] [Abstract][Full Text] [Related]
14. saRNAdb: Resource of Small Activating RNAs for Up-regulating the Gene Expression.
Dar SA; Kumar M
J Mol Biol; 2018 Jul; 430(15):2212-2218. PubMed ID: 29625201
[TBL] [Abstract][Full Text] [Related]
15. Novel RNA oligonucleotide improves liver function and inhibits liver carcinogenesis in vivo.
Reebye V; Sætrom P; Mintz PJ; Huang KW; Swiderski P; Peng L; Liu C; Liu X; Lindkaer-Jensen S; Zacharoulis D; Kostomitsopoulos N; Kasahara N; Nicholls JP; Jiao LR; Pai M; Spalding DR; Mizandari M; Chikovani T; Emara MM; Haoudi A; Tomalia DA; Rossi JJ; Habib NA
Hepatology; 2014 Jan; 59(1):216-27. PubMed ID: 23929703
[TBL] [Abstract][Full Text] [Related]
16. Targeted induction of endogenous NKX3-1 by small activating RNA inhibits prostate tumor growth.
Ren S; Kang MR; Wang J; Huang V; Place RF; Sun Y; Li LC
Prostate; 2013 Oct; 73(14):1591-601. PubMed ID: 23836514
[TBL] [Abstract][Full Text] [Related]
17. C/EBPalpha is up-regulated in a subset of hepatocellular carcinomas and plays a role in cell growth and proliferation.
Lu GD; Leung CH; Yan B; Tan CM; Low SY; Aung MO; Salto-Tellez M; Lim SG; Hooi SC
Gastroenterology; 2010 Aug; 139(2):632-43, 643.e1-4. PubMed ID: 20347819
[TBL] [Abstract][Full Text] [Related]
18. Yin Yang-1 suppresses differentiation of hepatocellular carcinoma cells through the downregulation of CCAAT/enhancer-binding protein alpha.
Zhang S; Jiang T; Feng L; Sun J; Lu H; Wang Q; Pan M; Huang D; Wang X; Wang L; Jin H
J Mol Med (Berl); 2012 Sep; 90(9):1069-77. PubMed ID: 22391813
[TBL] [Abstract][Full Text] [Related]
19. Transcriptional regulation of E-cadherin by small activating RNA: A new double-stranded RNA.
Wu Z; Li Y; Li Z; Liu Z; Qin Z; Li X; Ye Y; Bu L; Lin B; Wang Z; Jia G; Chen G
Int J Oncol; 2016 Oct; 49(4):1620-8. PubMed ID: 27498620
[TBL] [Abstract][Full Text] [Related]
20. Transcription onset of genes critical in liver carcinogenesis is epigenetically regulated by methylated DNA-binding protein MBD2.
Stefanska B; Suderman M; Machnes Z; Bhattacharyya B; Hallett M; Szyf M
Carcinogenesis; 2013 Dec; 34(12):2738-49. PubMed ID: 23955541
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
